Vitasora Health Limited (ASX:VHL)
0.0380
-0.0040 (-9.52%)
At close: May 2, 2025, 4:00 PM AEST
Vitasora Health Company Description
Vitasora Health Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States.
The company develops, produces, and sells mobile health applications. Its products include wheezo, a wheeze rate detector; respiri mobile application; and Respiri health portal.
It also provides critical patient health tracking services to clinicians and healthcare teams. The company was formerly known as Respiri Limited and changed its name to Vitasora Health Limited in April 2025.
The company was incorporated in 1987 and is based in Melbourne, Australia.
Vitasora Health Limited
Country | Australia |
Founded | 1987 |
Industry | Other |
Employees | 30 |
CEO | Marjan Mikel |
Contact Details
Address: 432 St Kilda Road Melbourne, 3004 Australia | |
Phone | 61 3 9653 9160 |
Website | respiri.co |
Stock Details
Ticker Symbol | VHL |
Exchange | Australian Securities Exchange |
Fiscal Year | July - June |
Reporting Currency | AUD |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Marjan Mikel | Chief Executive Officer |
Peter Hildebrandt | Chief Operating Officer |